Patients in Pain Are Outraged about New Hydrocodone Rules

On October 6, 2014, a Drug Enforcement Administration (DEA) decision to restrict access to hydrocodone combination pain relievers (HCPs) went into effect. Medications like Lortab, Norco, Vicodin and generic formulations have been moved from Schedule III to Schedule II. This may sound like a technicality, but the difference between these two categories is huge. A … Continue reading Patients in Pain Are Outraged about New Hydrocodone Rules